PIR® Treatment
What Is Physiologic Insulin Resensitization®?
Well Cell’s patented approach called Physiologic Insulin Resensitization® is directed by physicians to help patients with insulin resistance. The terms identify the PIR® protocol as a resource available to physicians and their QHPs to:
- Evaluate patients diagnosed with diabetes
- Use an FDA-approved pump for precision dosing
- Benefit from Well Cell’s training and teaching services
- Contribute to peer-reviewed publications
Through the use of Physician-Directed Physiologic Insulin Resensitization (PIR), the physician can administer insulin more precisely, as a hormone rather than a drug. Using insulin in a manner that bio-mimics normal physiology, PIR is designed to help physicians to reduce their patients’ insulin resistance, which may help blood sugar more readily enter each cell and be converted into energy.